Literature DB >> 7763636

Comparison of 5 microplate colorimetric assays for in vitro cytotoxicity testing and cell proliferation assays.

A Martin1, M Clynes.   

Abstract

This paper describes a critical comparative evaluation of 5 miniaturised colorimetric assays applicable to cytotoxicity testing of anti-tumour drugs (and other toxins) in vitro. Each assay shows a different linear range for optical density versus cell number, a different sensitivity to change in cell number and a different minimum detectable cell number; the values of these parameters vary with experimental conditions and with cell line used. All the methods gave good correlation with viable cell number (determined by colony forming efficiency) in toxicity assays after 3 or 4 days of treatment, but they underestimated cell death after 2 days. Toxicity levels for individual chemicals (in a standard 6-day assay) are similar for the different assays, irrespective of the mechanism of action of the chemical being tested. Two of the more recently developed assays (APNaOH and SRB) were found to be very sensitive under the conditions examined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7763636     DOI: 10.1007/BF00749057

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  17 in total

1.  In vitro toxicity of various classes of test agents using the neutral red assay on a human three-dimensional physiologic skin model.

Authors:  D Triglia; S S Braa; C Yonan; G K Naughton
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

2.  Evaluation of different staining procedures for the quantification of fibroblasts cultured in 96-well plates.

Authors:  M A Scragg; L R Ferreira
Journal:  Anal Biochem       Date:  1991-10       Impact factor: 3.365

3.  Quantification of cells cultured on 96-well plates.

Authors:  W Kueng; E Silber; U Eppenberger
Journal:  Anal Biochem       Date:  1989-10       Impact factor: 3.365

4.  Cytological differences between normal and malignant human cell populations in culture.

Authors:  U Gilvarry; D Farrell; V Lynch; M Moriarty; M Dooley; E Law; M Clynes
Journal:  Cancer Res       Date:  1990-06-01       Impact factor: 12.701

5.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

6.  In vitro chemosensitivity testing based on intracellular ATP levels (ATP assay).

Authors:  M Miura; K Kunitomo; N Komi
Journal:  Tokushima J Exp Med       Date:  1988-12

7.  Quantitative correlation of neutral red dye uptake with cell number in human cancer cell cultures.

Authors:  A G Fiennes; J Walton; D Winterbourne; D McGlashan; J Hermon-Taylor
Journal:  Cell Biol Int Rep       Date:  1987-05

8.  Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.

Authors:  D T Vistica; P Skehan; D Scudiero; A Monks; A Pittman; M R Boyd
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

9.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

10.  Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.

Authors:  Y P Keepers; P E Pizao; G J Peters; J van Ark-Otte; B Winograd; H M Pinedo
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

View more
  27 in total

1.  Cytokine sensitivity of metastatic human melanoma cell lines-- simultaneous inhibition of proliferation and enhancement of gelatinase activity.

Authors:  A Ladányi; J O Nagy; A Jeney; J Tímár
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

2.  Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest.

Authors:  Bíborka Bereczky; Réka Gilly; Erzsébet Rásó; Agnes Vágó; József Tímár; József Tóvári
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.

Authors:  Britta Stordal; Kirsten Timms; Angela Farrelly; Danielle Gallagher; Steven Busschots; Mickaël Renaud; Julien Thery; Deborah Williams; Jennifer Potter; Thanh Tran; Greg Korpanty; Mattia Cremona; Mark Carey; Jie Li; Yang Li; Ozlem Aslan; John J O'Leary; Gordon B Mills; Bryan T Hennessy
Journal:  Mol Oncol       Date:  2013-01-31       Impact factor: 6.603

4.  Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis.

Authors:  Pei-Feng Liu; Wenyuan Shi; Wenhong Zhu; Jeffery W Smith; Shie-Liang Hsieh; Richard L Gallo; Chun-Ming Huang
Journal:  Vaccine       Date:  2010-02-26       Impact factor: 3.641

5.  Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals.

Authors:  Michael W J Boehme; Peter Galle; Wolfgang Stremmel
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

6.  Glucocorticoid receptor expression and antiproliferative effect of dexamethasone on human melanoma cells.

Authors:  Judit Dobos; István Kenessey; József Tímár; Andrea Ladányi
Journal:  Pathol Oncol Res       Date:  2011-04-01       Impact factor: 3.201

7.  mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.

Authors:  C Daly; S Coyle; S McBride; L O'Driscoll; N Daly; K Scanlon; M Clynes
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

8.  Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines.

Authors:  M Heenan; K Kavanagh; A Redmond; M Maher; E Dolan; P O'Neill; M Moriarty; M Clynes
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

9.  Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines.

Authors:  D M Collins; J Crown; N O'Donovan; A Devery; F O'Sullivan; L O'Driscoll; M Clynes; R O'Connor
Journal:  Invest New Drugs       Date:  2009-06-05       Impact factor: 3.850

10.  Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines.

Authors:  Stacy S Shord; Shitalben R Patel
Journal:  J Exp Clin Cancer Res       Date:  2009-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.